Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 139 record(s)

Req # A-2020-001901

Any briefing notes, memos or similar documents provided to the Minister regarding the timelines of Canadian Agency for Drugs and Technologies in Health (CADTH’s) review process and pCPA’s backlog and Letter of Intent (LOI) process from January 1 2019 to March 24, 2021.

Organization: Health Canada

3 page(s)
July 2021

Req # A-2021-000224

The total cost of the Canadian Pain Task Force's work from the beginning to the release of its final report in April of this year. This would include total budget, and a breakdown of the total spent for all expenditures such as office rent, supplies, salaries, honoraria, consultants, travel, research and any other categories not mentioned here.

Organization: Health Canada

1 page(s)
July 2021

Req # A-2021-000315

By month, vehicle role, manufacturer model and trim, the total cost of maintenance for electric vehicles owned by the department. Limit timeframe of search from the start May 2019 to May 31, 2021.

Organization: Health Canada

1 page(s)
July 2021

Req # A-2019-001694

Adverse Reaction Reports (AERs). Report numbers: E2B_02763534, E2B_02764556, E2B_02764781, E2B_02764830.

Organization: Health Canada

113 page(s)
July 2021

Req # A-2019-001842

Adverse Drug Reaction (ADR). Report number: E2B_02805583.

Organization: Health Canada

19 page(s)
July 2021

Req # A-2019-001847

Adverse Drug Reaction (ADR). Report Number: E2B_02798893.

Organization: Health Canada

7 page(s)
July 2021

Req # A-2019-001914

Adverse Drug Reaction (ADR). Report number: 000728850.

Organization: Health Canada

3 page(s)
July 2021

Req # A-2020-000149

Adverse Reaction Reports (AERs). Report numbers: E2B_02958767, E2B_02959482, E2B_02960101, E2B_02962089.

Organization: Health Canada

68 page(s)
July 2021

Req # A-2020-000520

Adverse Drug Reaction (ADR) for DANAZOL. Report number: E2B_02941826.

Organization: Health Canada

25 page(s)
July 2021

Req # A-2020-000875

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108169-259, Exposure Notification - Consultation with the Office of the Privacy Commissioner.

Organization: Health Canada

5 page(s)
July 2021
Date modified: